Abstract 5329: Development of small molecule activators of protein phosphatase 2A for the treatment of lung cancer
Jaya Sangodkar(Pediatrics and Genetics), Goutham Narla(Pediatrics and Genetics), Sudeh Izadmehr(Icahn School of Medicine at Mount Sinai), Yiannis A. Ioannou(Icahn School of Medicine at Mount Sinai), Neelesh Sharma(Bayer (United States)), Sahar Mahzar(Case Comprehensive Cancer Center), Divya Hoon(Icahn School of Medicine at Mount Sinai), David B. Kastrinsky(Icahn School of Medicine at Mount Sinai), Daniela Schlatzer(Case Western Reserve University), Alain Borczuk, Shen Yao(Icahn School of Medicine at Mount Sinai), Michael Ohlmeyer(Princeton Satellite Systems (United States))
Cited by 0
Related Papers
Functional variants in the <i>LRRK2</i> gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease
|Science Translational Medicine|2018|410
Hepatic Niemann-Pick C1–like 1 regulates biliary cholesterol concentration and is a target of ezetimibe
|Journal of Clinical Investigation|2007|372
Transmembrane Molecular Pump Activity of Niemann-Pick C1 Protein
|Science|2000|324
Topological Analysis of Niemann-Pick C1 Protein Reveals That the Membrane Orientation of the Putative Sterol-sensing Domain Is Identical to Those of 3-Hydroxy-3-methylglutaryl-CoA Reductase and Sterol Regulatory Element Binding Protein Cleavage-activating Protein
|Journal of Biological Chemistry|2000|301